As a well-studied member of the NEET family, CISD2 has been linked to diseases like diabetes, obesity, aging, and neurodegeneration, and is increasingly recognized as a potential cancer treatment target (Kusminski et al., 2012; Chen et al., 2009). Here, CISD2 is linked to cancer.